Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study

Nikki C. C. Werkman,Gema García-Sáez,Johannes T. H. Nielen,Jose Tapia-Galisteo,Francisco J. Somolinos-Simón,Maria E. Hernando,Junfeng Wang,Li Jiu,Wim G. Goettsch,Carla J. H. van der Kallen,Annemarie Koster,Casper G. Schalkwijk,Hein de Vries,Nanne K. de Vries,Simone J. P. M. Eussen,Johanna H. M. Driessen,Coen D. A. Stehouwer
DOI: https://doi.org/10.1007/s00125-023-06082-4
IF: 8.2
2024-01-12
Diabetologia
Abstract:Type 2 diabetes is a highly heterogeneous disease for which new subgroups ('clusters') have been proposed based on disease severity: moderate age-related diabetes (MARD), moderate obesity-related diabetes (MOD), severe insulin-deficient diabetes (SIDD) and severe insulin-resistant diabetes (SIRD). It is unknown how disease severity is reflected in terms of quality of life in these clusters. Therefore, we aimed to investigate the cluster characteristics and cluster-wise evolution of quality of life in the previously defined clusters of type 2 diabetes.
endocrinology & metabolism
What problem does this paper attempt to address?